The Market For Cutting Balloon Catheters Is Expected To Expand At 4% CAGR From 2021-2031

The cutting balloon catheter, which is an inflatable balloon, was invented by Barath et al., and is used in angioplasty procedures. Percutaneous coronary interventions in arteries or veins are possible with these catheter devices. The device features a unique tip with microsurgical blades that are activated by inflating the balloon. When stents are used along with a balloon catheter, it is known as a balloon expandable stent, unlike self-expandable stents, and these are mostly made from nitinol alloy.

Rising cardiac diseases and old age population and numerous advantages of cutting balloon catheters are primary factors boosting the sales of cutting balloon catheters across geographies.
Moreover, the market is expected to grow due to rising prevalence of peripheral vascular diseases and also various developments in catheterization technology, thereby driving demand for angioplasty balloons.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:https://www.factmr.com/connectus/sample?flag=S&rep_id=145

𝗛𝗼𝘄 𝗮𝗿𝗲 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗙𝘂𝗲𝗹𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵?

The market for angioplasty balloons is expected to be driven by technological advancements and increased R&D. Furthermore, use of cutting balloon catheters for treatment is likely to increase among patients suffering from end-stage renal disease, with a majority of these patients undergoing catheter surgery.
Rising advanced cutting balloon catheter announcements by main players for coronary heart disease and peripheral heart disease treatment are expected to boost sales of cutting balloon catheter devices over the coming years.
Furthermore, growing cases of cardiovascular diseases require the development of more efficient cutting balloon catheters. Due to increased customer demand for such devices, cutting balloon catheter device manufacturers are concentrating their efforts on developing advanced products.

𝗪𝗵𝗶𝗰𝗵 𝗥𝗲𝗴𝗶𝗼𝗻 𝗶𝘀 𝗮 𝗟𝘂𝗰𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗳𝗼𝗿 𝗖𝘂𝘁𝘁𝗶𝗻𝗴 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿𝘀?

North America will continue to be the leading market for cutting balloon catheters over the next ten years. Revenue from the North American region will grow 1.3X by 2031.
Presence of well-established healthcare sector in the region is mainly responsible for this. Furthermore, factors such as growing healthcare expenditure and rising healthcare awareness are assisting market growth in the region. Also, because of increased regulatory approvals and product launches in the region, North America is expected holds the largest share in the market.
All in all, growing demand for coronary artery disease cutting balloon catheters in Canada, rising sales of nylon cutting balloon catheters in Argentina, and increasing demand for peripheral cutting balloon catheters in the U.K. are all making a significant contribution to global market growth prospects for cutting balloon catheters.

𝗪𝗵𝘆 𝗮𝗿𝗲 𝗖𝘂𝘁𝘁𝗶𝗻𝗴 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿𝘀 𝗳𝗼𝗿 𝗖𝗼𝗿𝗼𝗻𝗮𝗿𝘆 𝗔𝗿𝘁𝗲𝗿𝘆 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗚𝗮𝗶𝗻𝗶𝗻𝗴 𝗜𝗺𝗺𝗲𝗻𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝗿𝗶𝘁𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗠𝗮𝗿𝗸𝗲𝘁?

Demand for cutting balloon catheters for coronary artery disease is expected to increase 1.2X over the next ten years.
According to the Centers for Disease Control and Prevention (CDC), coronary artery disease was the leading cause of death in the United States in 2017, killing 365,914 people. Coronary artery disease (CAD), or coronary heart disease (CHD), is a severe disease that arises when plaque forms in the coronary arteries that supply oxygen-rich blood to the heart.
A cutting balloon catheter is an advanced percutaneous coronary intervention device. Without the need for open heart surgery, cutting balloon catheters help blood flow from the arteries to the heart muscles.
Technological advancements in angioplasty, rising rates of coronary artery disease, and increased adoption of cutting balloon catheters for coronary artery disease are expected to drive market growth.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:https://www.factmr.com/connectus/sample?flag=RC&rep_id=145

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Several major market players are concentrating their efforts on forming effective joint ventures, acquisitions, and/or collaborations to expand their respective customer bases. Leading manufacturers of cutting balloon catheters are concentrating their efforts on new product developments and launches to increase their market share.
With constant development in the healthcare industry, cutting balloon catheter manufacturers are keeping a record of the latest advancements to formulate key business strategies.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱:
• Abbott Laboratories
• Boston Scientific Corporation
• Terumo Corporation
• Medtronic Plc.
• B. Braun Melsungen AG
• BIOTRONIK SE & Co. KG
• Cordis Corporation
• Cook Medical Inc.
• MicroPort Scientific Corporation
• Cardionovum GmbH
• Meril Life Sciences Pvt Ltd
• Hexacath

𝗞𝗲𝘆 𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 𝗖𝗼𝘃𝗲𝗿𝗲𝗱 𝗶𝗻 𝗖𝘂𝘁𝘁𝗶𝗻𝗴 𝗕𝗮𝗹𝗹𝗼𝗼𝗻 𝗖𝗮𝘁𝗵𝗲𝘁𝗲𝗿 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

Indication
• Coronary Artery Disease
• Peripheral Vascular Disease

Raw Material
• Polyurethane
• Nylon
• Others

End User
• Hospitals
• Ambulatory Surgical Centers
• Cardiac Catheterization Laboratories

𝗙𝗼𝗿 𝗠𝗼𝗿𝗲 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀:

https://www.prnewswire.com/news-releases/inclination-towards-biodegradable-paints-to-elevate-oleate-esters-sales-at-5-8-cagr-in-2022--301569567.html

https://www.prnewswire.com/news-releases/surging-commercial-aircraft-production-to-offer-anaerobic-adhesives-us-1-bn-market-opportunity-by-2032-301571009.html

https://www.prnewswire.com/news-releases/facility-management-market-to-surpass-us-153-bn-registering-staggering-12-5-cagr-by-2032--301571759.html

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com

About Us:
Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.